Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial.

Yotsuyanagi H, Ohmagari N, Doi Y, Yamato M, Bac NH, Cha BK, Imamura T, Sonoyama T, Ichihashi G, Sanaki T, Tsuge Y, Uehara T, Mukae H

Open source

DOI: 10.1001/jamanetworkopen.2023.54991
Published: 2024 Feb 5
Container: JAMA network open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2023.54991,
  title = {Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial.},
  author = {Yotsuyanagi H and Ohmagari N and Doi Y and Yamato M and Bac NH and Cha BK and Imamura T and Sonoyama T and Ichihashi G and Sanaki T and Tsuge Y and Uehara T and Mukae H},
  year = {2024},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2023.54991},
  url = {https://doi.org/10.1001/jamanetworkopen.2023.54991}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial.
AU  - Yotsuyanagi H
AU  - Ohmagari N
AU  - Doi Y
AU  - Yamato M
AU  - Bac NH
AU  - Cha BK
AU  - Imamura T
AU  - Sonoyama T
AU  - Ichihashi G
AU  - Sanaki T
AU  - Tsuge Y
AU  - Uehara T
AU  - Mukae H
PY  - 2024
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2023.54991
UR  - https://doi.org/10.1001/jamanetworkopen.2023.54991
ER  -

APA

H, Y., N, O., Y, D., M, Y., NH, B., BK, C., T, I., T, S., G, I., T, S., Y, T., T, U., & H, M. (2024). Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2023.54991

Source records

pubmed · retrieved 2026-09-27T09:53:52.171Z